<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00931580</url>
  </required_header>
  <id_info>
    <org_study_id>1R01HD57126-01A2 UGA</org_study_id>
    <nct_id>NCT00931580</nct_id>
  </id_info>
  <brief_title>Vitamin D Needs of Early Adolescent Children</brief_title>
  <official_title>Supplemental Vitamin D and Functional Outcomes in Early Adolescence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Georgia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Purdue University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Indiana University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Georgia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      While a large percentage of children have low blood vitamin D levels, the significance of
      these low levels and the impact on health is unclear. The purpose of this project is to
      determine the effects of varying doses of vitamin D supplementation over 12 weeks on blood
      indicators of health in white and black children, aged 9 to 13 years, from both the northern
      and southern US.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Vitamin D intakes in children do not meet current US Dietary Reference Intake recommendations
      and emerging evidence suggests that a significant number of children, particularly those with
      darker skin pigmentation, have inadequate levels of serum 25-hydroxyvitamin D [25(OH)D]. The
      optimum level of circulating 25(OH)D has not been clearly defined in children, nor is it
      known what functional outcome measures are ideal for defining this level, or if these
      requirements would differ by race. Graded doses of vitamin D3 supplementation will be used in
      this dual-site, 12-week trial. The investigators hypothesize that a dose-response
      relationship will be observed between vitamin D supplementation and intermediate endpoints of
      skeletal health, and that race will modify these responses.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">April 2011</completion_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>serum 25(OH)D</measure>
    <time_frame>0 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>PTH</measure>
    <time_frame>0 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>1,25(OH)2D</measure>
    <time_frame>0 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>fractional calcium absorption</measure>
    <time_frame>0 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>biochemical markers of bone turnover</measure>
    <time_frame>0 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>serum 25(OH)D</measure>
    <time_frame>3 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>serum 25(OH)D</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>serum 25(OH)D</measure>
    <time_frame>9 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>serum 25(OH)D</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>PTH</measure>
    <time_frame>3 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>PTH</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>PTH</measure>
    <time_frame>9 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>PTH</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>1,25(OH)2D</measure>
    <time_frame>3 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>1,25(OH)2D</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>1,25(OH)2D</measure>
    <time_frame>9 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>1,25(OH)2D</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>fractional calcium absorption</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>biochemical markers of bone turnover</measure>
    <time_frame>3 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>biochemical markers of bone turnover</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>biochemical markers of bone turnover</measure>
    <time_frame>9 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>biochemical markers of bone turnover</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>sunlight exposure</measure>
    <time_frame>0 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>dietary data</measure>
    <time_frame>0 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>physical activity data</measure>
    <time_frame>0 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serum and urinary calcium</measure>
    <time_frame>0 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>body composition</measure>
    <time_frame>0 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sunlight exposure</measure>
    <time_frame>3 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sunlight exposure</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sunlight exposure</measure>
    <time_frame>9 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sunlight exposure</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>dietary data</measure>
    <time_frame>3 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>dietary data</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>dietary data</measure>
    <time_frame>9 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>dietary data</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>physical activity data</measure>
    <time_frame>3 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>physical activity data</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>physical activity data</measure>
    <time_frame>9 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>physical activity data</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serum and urinary calcium</measure>
    <time_frame>3 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serum and urinary calcium</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serum and urinary calcium</measure>
    <time_frame>9 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serum and urinary calcium</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>body composition</measure>
    <time_frame>3 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>body composition</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>body composition</measure>
    <time_frame>9 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>body composition</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">323</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo tablet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>400 IU</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vitamin D3 tablet, 400 IU</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1,000 IU</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vitamin D3 tablet, 1,000 IU</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2,000 IU</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vitamin D3 tablet, 2,000 IU</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4,000 IU</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vitamin D3 tablet, 4,000 IU</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D3</intervention_name>
    <description>vitamin D3 supplementation at 400 IU vs 1,000 IU vs 2,000 IU vs 4,000 IU vs placebo for 12-weeks</description>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_label>400 IU</arm_group_label>
    <arm_group_label>1,000 IU</arm_group_label>
    <arm_group_label>2,000 IU</arm_group_label>
    <arm_group_label>4,000 IU</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy

          -  Non-Hispanic

          -  Male, 10-13 years of age or female 9-11 years of age

          -  Within genitalia or breast stage 2/3

          -  Willing to provide blood/urine samples

          -  Free from taking vitamin, mineral or herbal supplements

          -  Able to swallow tablets

        Exclusion Criteria:

          -  Menarche (females)

          -  Known bone diseases or disease known to influence bone metabolism (e.g. cerebral
             palsy, intestinal malabsorption, juvenile rheumatoid arthritis)

          -  Known growth disorder

          -  The use of medications that influence bone metabolism (e.g. corticosteroids, Attention
             Deficit Hyperactivity Disorder (ADHD) medications).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>9 Years</minimum_age>
    <maximum_age>13 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard D Lewis, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Georgia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The University of Georgia Dept of Foods &amp; Nutrition</name>
      <address>
        <city>Athens</city>
        <state>Georgia</state>
        <zip>30602</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Indiana University School of Medicine</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Purdue University</name>
      <address>
        <city>West Lafayette</city>
        <state>Indiana</state>
        <zip>47907</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Lewis RD, Laing EM, Hill Gallant KM, Hall DB, McCabe GP, Hausman DB, Martin BR, Warden SJ, Peacock M, Weaver CM. A randomized trial of vitamin D₃ supplementation in children: dose-response effects on vitamin D metabolites and calcium absorption. J Clin Endocrinol Metab. 2013 Dec;98(12):4816-25. doi: 10.1210/jc.2013-2728. Epub 2013 Oct 3.</citation>
    <PMID>24092833</PMID>
  </results_reference>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 1, 2009</study_first_submitted>
  <study_first_submitted_qc>July 1, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 2, 2009</study_first_posted>
  <last_update_submitted>September 23, 2015</last_update_submitted>
  <last_update_submitted_qc>September 23, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 25, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Georgia</investigator_affiliation>
    <investigator_full_name>Dr. Richard D. Lewis</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Vitamin D</keyword>
  <keyword>Adolescent</keyword>
  <keyword>African American</keyword>
  <keyword>White</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

